• Home
  • Targeting Stat3 abrogates EGFR inhibitor resistance in cancer.

Targeting Stat3 abrogates EGFR inhibitor resistance in cancer.

Author List
Sen M, Joyce S, Panahandeh M, Li C, Thomas SM, Maxwell J, Wang L, Gooding WE, Johnson DE, Grandis JR
Publication
Clinical cancer research : an official journal of the American Association for Cancer Research
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1164356
Publication Year
2012
PubMed ID
22825581
Publication Title
Sen M, Joyce S, Panahandeh M, Li C, Thomas SM, Maxwell J, Wang L, Gooding WE, Johnson DE, Grandis JR. Targeting Stat3 abrogates EGFR inhibitor resistance in cancer. Clin Cancer Res. 2012 Sep 15; 18(18):4986-96.